Welcome to Thrombosis Adviser

A Venous & Arterial Thrombosis Resource
For

Adviser’s Picks

  • VTE Treatment in Challenging Patient Populations
    Read more
  • Dosing Schemas of the NOACs for VTE Treatment
    Read more
  • Are NOACs Associated with Better Renal Outcomes than VKAs in Patients with NVAF?
    Read more
  • ESC Heart and Stroke Conference Highlights
    Read more
  • Improving AF Detection: The Evolving Role of Technology in Stroke Prevention
    Read more
  • LINC 2019 Highlights
    Read more
  • Interpreting Safety Results of NOACs Based on Bleeding Risk
    Read more
  • Managing the multi-morbid patient with AF: Focus on patients with renal impairment
    Read more
  • Professor Craig I. Coleman about challenges in interpreting real-world studies involving the NOACs
    Read more
  • Extended Treatment of VTE: In Whom and at Which Dose?
    Read more
  • Further Advances on the Use of NOACs in Patients with AF Undergoing PCI
    Read more
  • 10 Years of Anticoagulation with the NOACs
    Read more
  • Managing Multimorbid Patient with Atrial Fibrillation
    Read more
  • Dual pathway strategy for secondary prevention of atherothrombotic events: the anticoagulant and antiplatelet mix
    Read more
  • Extended VTE treatment: insights from new data
    Read more
  • Cardioversion and Ablation: an Overview of Completed Studies and Clinical Perspectives
    Read more
  • Management of Patients with Atrial Fibrillation and Coronary Artery Disease: Practical Perspectives from PIONEER AF-PCI
    Read more
  • Impact of Common Co-Morbidities on Patient Selection for Non-Vitamin K Antagonist Oral Anticoagulants
    Read more
  • Results of the PIONEER AF-PCI Trial
    Read more
When to use a reduced NOAC dose 02:12 min
Join the Conversation

Join the Conversation

Thrombosis Connection, A Healthcare Professionals’ Forum welcomes individuals interested in sharing, developing and fostering innovative solutions in the field of thrombosis.

Join LinkedIn Group